Related Experiment Video
Updated: Jun 4, 2026

Monitoring Tumor Metastases and Osteolytic Lesions with Bioluminescence and Micro CT Imaging
Published on: April 14, 2011
[Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL]
1Department of Medical Oncology, Cancer Institute Hospital, Japanese Fonundation for Cancer Research.
Abstract:
Various cancer treatments can cause gonadal dysfunction and bone loss. Especially, endocrine therapies for breast cancer or prostate cancer carry a significant risk of cancer treatment-induced bone loss (CTIBL) . LHRH agonist- or chemotherapy-induced premature menopause in premenopausal breast cancer patients, aromatase inhibitor in postmenopausal breast cancer patients, and LHRH agonist with or without anti-androgen in prostate cancer patients may cause bone loss of 5% or more within several years. Oral or intravenous bisphosphonates are effective for prevention of CTIBL, and RANKL antibody (denosumab) is also effective. During treatment, physicians should follow bone mineral density and avoid QOL impairment due to osoteoporosis.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

